Search Results - Reena S. Cecchini
- Showing 1 - 4 results of 4
-
1
-
2
Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30 by N. Lynn Henry, Sungjin Kim, Ron D. Hays, Marcio A. Diniz, Mourad Tighiouart, Gillian Gresham, Michael Luu, Reena S. Cecchini, Greg Yothers, André Rogatko, Patricia A. Ganz
Published 2022-11-01
Article -
3
Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial by Pooja P. Advani, Kathryn J. Ruddy, Joerg Herrmann, Jordan C. Ray, Emily C. Craver, Greg Yothers, Greg Yothers, Reena S. Cecchini, Reena S. Cecchini, Corey Lipchik, Huichen Feng, Priya Rastogi, Priya Rastogi, Eleftherios P. Mamounas, Eleftherios P. Mamounas, Sandra M. Swain, Sandra M. Swain, Charles E. Geyer, Charles E. Geyer, Norman Wolmark, Norman Wolmark, Soonmyung Paik, Katherine L. Pogue-Geile, Gerardo Colon-Otero, Edith A. Perez, Nadine Norton
Published 2023-05-01
Article -
4
NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab by Patricia A. Ganz, Reena S. Cecchini, Louis Fehrenbacher, Charles E. Geyer, Priya Rastogi, John P. Crown, Michael P. Thirlwell, David M. Ellison, Jean-Francois Boileau, Patrick J. Flynn, Jong-Hyeon Jeong, Eleftherios P. Mamounas, Norman Wolmark
Published 2021-05-01
Article